P21

FDA APPROVAL PENDING

Emerging

Cognitive

Longevity

Cognitive

P21

Longevity

Amino acid sequence

4

Amino acids

578.7da

Molecular weight

Peptide

Type

P21 is a nootropic peptide derived from ciliary neurotrophic factor (CNTF) that enhances neurogenesis and cognitive function. It contains an adamantane moiety that enables blood-brain barrier penetration. Research shows it increases BDNF expression, inhibits LIF signaling to promote neurogenesis, and reduces tau and amyloid pathology in Alzheimer's disease models. Remarkably, P21 can boost neurogenesis in diseased brains above levels seen in healthy untreated brains.

Top researched benefits

Overview of P21

P21 operates through multiple pathways: it inhibits leukemia inhibitory factor (LIF) signaling, removing a key roadblock to neurogenesis and shifting the brain toward a more embryologic state favoring neuron growth. It increases brain-derived neurotrophic factor (BDNF) expression and activates the BDNF/TrkB/PI3-K/AKT/GSK3β pathway. This pathway modulation improves cognitive function and reduces tau and amyloid pathologies.

Neurodegenerative Disease

  • P021 markedly reduced tau pathology, attenuated Aβ generation, and rescued episodic memory impairment in 3xTg-AD mice.
  • Treatment during synaptic compensation period can prevent neurodegeneration and reduce mortality.
  • Robust attenuation of tau pathologies through BDNF/TrkB/PI3-K/AKT/GSK3β pathway.

Cognitive Enhancement

  • Enhances dentate gyrus neurogenesis so effectively it exceeds levels in healthy untreated brains.
  • Enhances memory processes through increased BDNF and restored synaptic function.
  • May reduce natural decline in learning and memory in aged models by rescuing neurogenesis deficit.

Neuroprotection

  • Restores synaptic deficits in cortex and hippocampus.
  • Rescues deficits in neuronal plasticity.

Storage

Refrigerate at 2-8°C

Frequency

Daily in animal research protocols

Typical Dose

Research compound - dosing not established for humans

Cycle Duration

Not established - experimental peptide without human trials

Chemical Makeup

Key benefits

Potent promotion of neurogenesis in the dentate gyrus

Increased BDNF expression

Reduced tau protein pathology

Reduced amyloid-beta plaque formation

Improved cognitive function and memory

Restored synaptic deficits in cortex and hippocampus

Reduced mortality rate in AD models

Crosses blood-brain barrier effectively

Community interest

This peptide is still gaining traction in the community.

P021 | CNTF-Derived Neurogenic Peptide

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

P21 Molecular Information

View the scientifc details of P21.

4

Amino Acids

P21

Asp

Asp

Position 1

Gly

Gly

Position 2

Gly

Gly

Position 3

Leu

Leu

Position 4

Amino acid sequence
Aspartic acidPosition 1
GlycinePosition 2
GlycinePosition 3
LeucinePosition 4

Molecular Weight

578.7Da

Chain Length

4Amino Acids

Type

Peptide

P21 Protocols

P21 has not yet been tested in human clinical trials. Research protocols in animal models use subcutaneous or intraperitoneal injection. The adamantane moiety enables blood-brain barrier penetration for CNS effects.

GoalDosageFrequencyRoute
Research protocol—1 week rangeSubQ or IP

Reconstitution Instructions

Materials needed:

Bacteriostatic water (BAC)Insulin syringesAlcohol swabsPeptide vialSterile work surface

Steps to reconstitute

  1. Clean work area and hands thoroughly
  2. Calculate required BAC water volume
  3. Draw BAC water into syringe
  4. Inject slowly down vial side
  5. Gently swirl until dissolved (never shake)
  6. Store in refrigerator

P21 Cycle

The P21 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
BDNF elevation begins
Week 0-0
Neurogenesis enhancement measurable
Week 0-0
Cognitive improvements in research models
Week 0-0
Disease-modifying effects in AD models

Dosing tools

P21 Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

P21

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg P21 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
P21
Dosing
Research compound - dosing not established for humans
Dosing Frequency
Daily in animal research protocols
Cycle Duration
Not established - experimental peptide without human trials
Storage
Refrigerate at 2-8°C

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
  • Inject water slowly — aim down the vial wall, not directly onto powder
  • Never shake — gently swirl or roll the vial until dissolved
  • Store properly — refrigerate at 2-8°C after reconstitution
  • Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
  • Keep sterile — always clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of P21 interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No known negative interactions; different mechanisms.

COMPATIBLE

Cognitive

dih

Longevity

Dihexa

COMPATIBLE

Both promote neurogenesis through different pathways.

COMPATIBLE

Cognitive

sema

Longevity

Semax

COMPATIBLE

Different nootropic mechanisms; may complement each other.

COMPATIBLE

Side effects

Contraindications

Not approved for human use

Pregnancy or breastfeeding

Unknown safety profile in humans

Stop signs

Allergic reactions

Unusual neurological symptoms

Bad signs

DiscolorationCloudy solutionParticulates visible
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

P21Research References

P21 is an emerging compound

4Research references

P21

P21 is an emerging compound

P021 Treatment in 3xTg-AD Mice

P021 markedly reduced tau pathology, attenuated Aβ, rescued episodic memory, and reduced mortality in AD mice.

n.d.

P21 and BDNF/TrkB Pathway

Disease-modifying effect via BDNF/TrkB/PI3-K/AKT/GSK3β pathway; rescued neurogenesis and cognition.

n.d.

P21 in Cognitive Aging

May reduce age-related cognitive decline by restoring BDNF expression and synaptic function.

n.d.

P21 as Promising AD Drug Candidate

Beneficial effects in preclinical studies make P21 highly promising for AD drug development.

n.d.